TCM
XLRN
Tekla Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-40,606
| Closed | -$3.87M | – | 227 |
|
|
2020
Q2 | $3.87M | Hold |
40,606
| – | – | 0.15% | 113 |
|
|
2020
Q1 | $3.65M | Sell |
40,606
-45,707
| -53% | -$4.11M | 0.17% | 104 |
|
|
2019
Q4 | $4.58M | Hold |
86,313
| – | – | 0.17% | 110 |
|
|
2019
Q3 | $3.41M | Sell |
86,313
-102,075
| -54% | -$4.03M | 0.15% | 106 |
|
|
2019
Q2 | $7.74M | Hold |
188,388
| – | – | 0.32% | 71 |
|
|
2019
Q1 | $8.77M | Buy |
188,388
+17,622
| +10% | +$821K | 0.36% | 62 |
|
|
2018
Q4 | $7.44M | Hold |
170,766
| – | – | 0.32% | 65 |
|
|
2018
Q3 | $9.77M | Hold |
170,766
| – | – | 0.35% | 66 |
|
|
2018
Q2 | $8.29M | Sell |
170,766
-102,332
| -37% | -$4.97M | 0.31% | 73 |
|
|
2018
Q1 | $10.7M | Sell |
273,098
-10,285
| -4% | -$402K | 0.42% | 53 |
|
|
2017
Q4 | $12M | Buy |
283,383
+223,729
| +375% | +$9.5M | 0.46% | 47 |
|
|
2017
Q3 | $2.23M | Hold |
59,654
| – | – | 0.08% | 115 |
|
|
2017
Q2 | $1.81M | Buy |
59,654
+5,204
| +10% | +$158K | 0.07% | 115 |
|
|
2017
Q1 | $1.44M | Hold |
54,450
| – | – | 0.06% | 119 |
|
|
2016
Q4 | $1.39M | Buy |
+54,450
| New | +$1.39M | 0.06% | 117 |
|